Categories
Executive Movements

Illumina announces CEO transition plan

Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced that its Board of Directors has accepted the resignation of Francis deSouza as Illumina’s Chief Executive Officer and as a Director, effective Sunday, June 11.  Charles Dadswell, Senior Vice President and General Counsel, has been named interim CEO while the Board of Directors conducts […]

Categories
Executive Movements

Illumina appoints Joydeep Goswami as Chief Financial Officer

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced Joydeep Goswami has been appointed Chief Financial Officer, effective immediately. Goswami previously served as Illumina’s Chief Strategy and Corporate Development Officer and interim Chief Financial Officer. As CFO, Goswami will be responsible for the Company’s financial planning and analysis, accounting, investor relations, internal audit, tax, […]

Categories
Executive Movements

Joydeep Goswami appointed interim CFO of Illumina

Illumina, Inc., a DNA sequencing company, announced Joydeep Goswami, Chief Strategy and Corporate Development Officer, will also serve as interim Chief Financial Officer while the company conducts a search for a permanent CFO. Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years. In addition to Goswami’s current responsibilities, which […]

Categories
Investment

Cancer screening startup GRAIL to be acquired by Illumina

Illumina and GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, announced they have entered into a definitive agreement under which Illumina will acquire GRAIL for cash and stock consideration of $8 billion upon closing of the transaction.  In addition, GRAIL stockholders will receive future payments representing a tiered single digit percentage […]